Health
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma – News-Medical.Net
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors…
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects.
Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively…
-
General14 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
General19 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
Noosa News18 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business18 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?